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Abstract
Background: Vitamin K is essential for the posttranslational modification of various Gla proteins. Although it is
widespread in several organs, including the testis, the function of vitamin K in these organs is not well
characterized. In this study, we investigated the function of vitamin K in the testis and analyzed its role in
steroidogenesis.
Methods: Eight-week-old male Wistar rats were fed a diet supplemented with menaquinone-4 (MK-4, 75 mg/kg
diet), one of the predominant K2 vitamins present in the testis, for 5 weeks. In vivo testosterone levels of the rats’
plasma and testes were measured by enzyme-linked immunosorbent assay, and in vitro testosterone levels of
testis-derived tumor cells (I-10 cells) maintained in Ham’s F-10 medium with 10% fetal bovine serum were
measured following treatment with MK-4 (0 to 100 μM) at several time points. Testosterone and cellular protein
levels were analyzed with respect to their effects on steroidogenesis.
Results: Testosterone levels in the plasma and testes of MK-4-fed rats were significantly increased compared to
those of control rats, with no obvious differences in plasma luteinizing hormone levels. Secreted testosterone levels
from I-10 cells were elevated by MK-4, but not by vitamin K1, in a dose-dependent manner independent of cAMP
treatment. Western blot analysis revealed that expression of CYP11A, the rate-limiting enzyme in steroidogenesis,
and phosphorylation levels of protein kinase A (PKA) and the cAMP response element-binding protein were all
stimulated by the presence of MK-4. Enhancement of testosterone production was inhibited by H89, a specific
inhibitor of PKA, but not by warfarin, an inhibitor of g-glutamylcarboxylation.
Conclusions: MK-4 stimulates testosterone production in rats and testis-derived tumor cells via activation of PKA.
MK-4 may be involved in steroidogenesis in the testis, and its supplementation could reverse the downregulation
of testosterone production in elders.
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Background
Vitamin K acts as the cofactor of g-glutamylcarboxylase,
which converts specific glutamate residues into g-car-
boxyglutamate (Gla) in blood coagulation factors and
bone matrix proteins [1,2]. Two types of naturally-
occurring vitamin K molecules have been identified:
phylloquinone (vitamin K1) and menaquinones (vitamin
K2). Vitamin K1 is synthesized and stored in green vege-
tables, whereas vitamin K2 is mainly produced by
microorganisms and is enriched for in fermented foods.
Menaquinone-4 (MK-4), an analogue of vitamin K2,
contains a geranylgeranyl group (four isoprene units) as
a side chain and is obtained from the conversion of vita-
min K1 and other menaquinones in various animal tis-
sues and cultured cells [3-8]. In rodents, MK-4 is
observed in not only the liver and bone, but in organs
such as the brain, pancreas, and gonadal tissues as well.
Novel functions of vitamin K1 and MK-4 have been
reported recently [1], but the detailed mechanism and
physiological significance of the conversion of vitamin
K1 to MK-4 in various tissues remains to be elucidated.
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specific functions: i) spermatogonia and its differentiated
cells, which are located in the seminiferous tubules; ii)
Leydig cells, which produce sex hormones and are dis-
tributed in the connective tissue of the convoluted semi-
niferous tubules; and iii) Sertoli cells, which form the
basement membrane of the seminiferous tubules and
offer the environment necessary for the differentiation
and maturation of germ cells [9]. Leydig cells synthesize
and secrete testosterone and are dependent on luteiniz-
ing hormone (LH), which is secreted from the pituitary
gland. The LH receptor, a G-protein-coupled receptor
located on the surface membrane of Leydig cells, stimu-
lates adenylate cyclase and elevates intracellular cyclic-
AMP (cAMP) levels after interaction with LH, followed
by activation of protein kinase A (PKA) and other ster-
oidogenic proteins. Steroidogenic acute regulatory pro-
tein (StAR) transports cholesterol into the inner
membrane of mitochondria, and the enzyme CYP11A
catalyzes the production of pregnenolone from trans-
ported cholesterol; these two proteins control key steps
in the conversion of cholesterol to testosterone [10].
I nap r e v i o u ss t u d y ,w ep e r f o r m e dac o m p r e h e n s i v e
gene expression analysis to elucidate the functions of
vitamin K in the testis [11] and found that mRNA levels
of steroidogenic genes were significantly reduced in the
testis of vitamin K-deficient rats, accompanied by low
testosterone levels in the rats’ testis and plasma. In this
current study, we further explored the effects of vitamin
K on testosterone production in rat testes and tumor-
derived Leydig cells.
Methods
Materials
MK-4 and vitamin K1 were obtained from Nisshin
Pharma Inc. (Tokyo, Japan) and Wako Pure Chemicals
(Osaka, Japan), respectively. All vitamin K analogues
were dissolved in ethanol at 20 mM and stored at -20°C
with protection from light until used to maintain their
stability. When vitamin K was added to the cell culture
medium, the final concentration of ethanol as solvent
was adjusted to 0.5%. Dibutyryl cyclic-AMP (db-cAMP),
forskolin (FSK), and N-[2-(p-bromocinnamylamino)
ethyl]-5-isoquinoline sulfonamide (H89), which is a pro-
tein kinase A (PKA)-specific inhibitor, were purchased
from Sigma (St. Louis, MO), and warfarin potassium
was obtained from Eisai Co. Other reagents were pur-
chased from Wako Pure Chemicals.
Animals and diets
Male Wistar rats were purchased from Japan SLC, (Shi-
zuoka, Japan) and kept in a specific pathogen-free
unsterilized animal house. Rats were maintained on an
open formula, non-purified diet (Funabashi Farms Co.,
Japan) until the start of the experiment, at which time
they were 8 weeks of age. All animals were housed in
individual cages, each with a wire-mesh floor, at 23°C ±
2°C on a 12:12 light:dark cycle (lights on at 8:00). Con-
trol (Cont) and MK-4-supplemented (MK-4 sup) diets
were prepared by adding vitamin K1 or MK-4 to the
vitamin K-free AIN-93G-based standard diet (final con-
centrations of 0.75 and 75 mg/kg diet, respectively). The
concentration of vitamin K1 i nt h eC o n td i e tw a sb a s e d
on the AIN-93G formula [12].
Ethical guidelines
T h ee x p e r i m e n t a lp l a nf o rt h ep r e s e n ts t u d yw a s
approved by the Animal Research Animal Care Com-
mittee of the Graduate School of Agricultural Science,
Tohoku University. All experiments followed the guide-
lines issued by that committee in accordance with the
Japanese government legislation (1980), which super-
vised the care and use of the rats in the present study.
Cell culture
Leydig tumor cells from mice (I-10) and rats (R2C) were
obtained from the Health Science Research Resources
Bank (Osaka, Japan) and maintained in Ham’sF - 1 0
medium (Sigma) supplemented with 10% fetal bovine
serum (Biowest, Nuaillé, France), 50 U/mL penicillin,
and 50 mg/mL streptomycin at 37°C in a 5% CO2 atmo-
sphere. Both cell types were seeded into12-well plates at
a density of 6.0 × 10
4 cells per well and incubated over-
night. The culture medium was then replaced with fresh
medium, and MK-4 was added to the cells at final con-
centrations of 0, 3, 10, 30, or 100 μM.
Measurement of testosterone and luteinizing hormone
Cell culture media of I-10 and R2C cells were collected
and centrifuged at 1,000 × g for 5 min. Concentrations
of testosterone in the supernatants were determined
using the testosterone EIA kit (Cayman Chemical, Ann
Arbor, MI). Testosterone in the rats’ plasma and testis
was extracted twice in five volumes of diethyl ether.
After extraction, the organic phase was collected by cen-
trifugation at 1,500 × g for 5 min and evaporated using
a vacuum centrifugal evaporator. The extract was resus-
pended in an adequate volume of EIA buffer from the
kit. The luteinizing hormone (LH) concentration in the
plasma was determined using a rodent LH enzyme-
linked immunosorbent assay (ELISA) test kit purchased
from Endocrine Technologies (Newark, CA).
Cell growth assays
I-10 cells were seeded into 96-well plates at a density of
1.2 × 10
4 cells/well. The medium was changed the fol-
lowing day, and MK-4 was added to final concentrations
of 0, 3, 10, 30, or 100 μM. Following incubation for 24
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mined using the Premix WST-1 Cell Proliferation Assay
System (Takara Bio Inc., Shiga, Japan) according to the
manufacturer’s instructions.
Western blot analysis
Whole cell extracts of I-10 cells were prepared using
lysis buffer (50 mM HEPES-NaOH (pH 7.5), 150 mM
N a C l ,1 0 %g l y c e r o l ,1 %T r i t o nX - 1 0 0 ,a n d1 . 5m M
MgCl2) containing proteinase inhibitors (Complete Pro-
teinase Inhibitor Cocktail, Roche Applied Science, Man-
nheim, Germany) and phosphatase inhibitors
(PhosSTOP Phosphatase Inhibitor Cocktail, Roche
Applied Science). Rat testis tissue was homogenized in
PBS buffer containing 1 mM phenylmethylsulfonyl
fluoride. The protein concentration in the lysate was
measured with a protein assay reagent (Bio-Rad, Her-
cules, CA). The proteins were denatured in an SDS gel-
loading buffer, resolved by 10% SDS-polyacrylamide gel
electrophoresis, and transferred onto a polyvinylidene
fluoride membrane (Millipore, Billerica, MA). After
blocking for 1 h with TBS-T (10 mM Tris-HCl pH 7.4,
150 mM NaCl, and 0.1% Tween 20) containing 5%
bovine serum albumin (Sigma), the membrane was incu-
bated with anti-phospho PKA, anti-PKA, anti-phospho
CREB (Cell Signaling Technology, Danvers, MA), anti-
CREB (Sigma), anti-StAR (Affinity Bioreagents, Golden,
CO), and anti-CYP11A (Chemicon, Temecula, CA) and
then visualized with the Immobilon Western reagent
(Millipore) using a LAS-4000 mini luminescent image
analyzer (Fujifilm, Tokyo, Japan). The relative expression
level of each protein was normalized according to the
amount of a-tubulin or b-actin detected by their respec-
tive antibodies (Sigma and Abcam, Tokyo, Japan).
Measurement of vitamin K content in cultured cells and
organs by HPLC
Cultured cells and tissue samples were homogenized in
five volumes of 66% 2-propanol. Vitamin K was then
extracted from the homogenate with six volumes of n-
hexane as previously described [13] and measured using
a fluorescence-HPLC system (Waters 600E system;
Puresil 5C18 column, Waters, Milford, MA; RC 10-3
PtO2 column, Shiseido-Irica, Kyoto, Japan; Hitachi F-
1000 fluorescence detector, excitation at 240 nm, emis-
sion at 430 nm; Hitachi D-2000 data processor, Tokyo,
Japan). The vitamin K1 and MK-4 concentrations in the
tissues were determined by measuring their relative
fluorescence intensities using menaquinone-3 (MK-3) as
an internal standard [11,13]. Vitamin K levels in cul-
tured cells were determined by the same procedure
except that menaquinone-5 (MK-5) was used as an
internal standard instead of MK-3. MK-3 and MK-5
were obtained from Eisai Co. (Tokyo, Japan)
Statistical analysis
The results are expressed as mean ± standard error (SE).
D a t ai nT a b l e1 ,F i g u r e s1 B ,C ,a n d6 Bw e r ea n a l y z e d
using the Student’s t test. The data in Figures 2, 3A, C,
4, 5, 6A, 7, and 8 were analyzed statistically by one-way
analysis of variance (ANOVA), and multiple compari-
sons were performed using Tukey’s test. The time-
course data of plasma testosterone concentrations in
samples obtained from the tail vein (Figure 1A) were
analyzed by two-way repeated measures ANOVA fol-
lowed by Tukey’s multiple-comparison test. Data in Fig-
u r e3 Bw e r ea n a l y z e db yt w o - w a yA N O V A ,a n d
multiple comparisons were performed using Tukey’s
test. Statistical analyses were performed using the Stat-
celQC program (OMS Publishing, Saitama, Japan) and
SigmaPlot 12 (Systat Software, Inc., Chicago, IL).
Results
Effect of menaquinone-4 supplemented diet on
testosterone level in rat testis
Male Wistar rats were fed either a control (Cont) or MK-
4-supplemented (MK-4 sup) diet for 5 weeks. After
experimental feeding, the overall body weights and rela-
tive weights of the liver and testis were not significantly
different between the groups (data not shown). Table 1
shows vitamin K concentrations in the liver and testis as
determined by fluorescence-HPLC, which illustrates that
vitamin K levels in these tissues were strongly affected by
the different diets. Specifically, the amount of vitamin K1
in tissues from the MK-4 sup group was significantly
lower than that in the Cont group, and as expected, MK-
4 levels were significantly higher in the MK-4 sup group
when compared to that of the Cont group. Testosterone
levels in plasma obtained from the tail vein were higher
in the MK-4 sup group beginning from the second week
of the experiment until the end of the experiment (Figure
1A). Increased plasma testosterone levels in the MK-4
sup group were statistically significant compared with
those of the control, and testosterone levels in MK-4 sup
g r o u pa tw e e k s3a n d5w e r es i g n i f i c a n t l yh i g h e rt h a n
those of Cont group. At the end of the experimental
feeding period, testosterone levels in the testis were sig-
nificantly increased in the MK-4 sup group, although
plasma levels of luteinizing hormone (LH) remained
unchanged (Figures 1B and 1C). Therefore, an MK-4-
supplemented diet can enhance testosterone production
in the testis in a manner that is independent of LH.
Effect of menaquinone-4 on testosterone production in
mouse testis tumor cells (I-10 cells)
Mouse I-10 cells have a phenotype similar to that of Ley-
dig cells in that they synthesize and secrete testosterone,
which is dependent on intracellular cAMP levels [14]. Tes-
tosterone levels in the cell culture medium after addition
Ito et al. Lipids in Health and Disease 2011, 10:158
http://www.lipidworld.com/content/10/1/158
Page 3 of 9of dibutyryl cAMP (db-cAMP, 3 μM) were significantly
increased compared to control cells that were not treated
with db-cAMP (Figure 2A). In addition, treatment of I-10
cells with MK-4 in the presence of db-cAMP was found to
significantly enhance testosterone secretion into the cul-
ture medium, and the maximum enhancement of secre-
tion was observed when 30 μM MK-4 was present in the
medium. Leydig cells secrete testosterone in a diffusive
manner [15]; therefore, MK-4 directly enhances testoster-
one synthesis in the cells rather than only affecting release
of testosterone from the cells. Because MK-4 induces
apoptosis in several types of tumor cells [16] and osteo-
clast cells [17] and inhibits growth of hepatocarcinoma
cells [18,19], we evaluated the effect of MK-4 on I-10 cell
growth and viability. Our results showed that MK-4 did
not promote cell growth but rather inhibited I-10 cell
growth in a dose-dependent manner (Figure 2B).
Table 1 Vitamin K1 and menaquinone-4 concentrations in liver and testis
Organ Liver Testis
Vitamin K1 Menaquinone-4 Vitamin K1 Menaquinone-4
Cont (n = 8) 212.7 ± 20.72
a 0.634 ± 0.529 7.331 ± 1.621 189.5 ± 8.823
MK-4 sup (n = 7) 77.82 ± 6.415** 2016.8 ± 359.1** 1.481 ± 1.516* 995.9 ± 111.6**
aEach value is the mean ± SE (pmol/g tissue). Values are significantly different from those of the Cont group at *p < 0.05, **p < 0.01.
7LPH䋨ZNV䋩
&RQW
0.VXS

7
H
V
W
R
V
W
H
U
R
Q
H


Q
J

P
O













0.
VXS
&RQW
7
H
V
W
R
V
W
H
U
R
Q
H

Q
J

P
J

S
U
R
W
H
L
Q








0.
VXS
&RQW
/
X
W
H
L
Q
L
]
L
Q
J

K
R
U
P
R
Q
H


Q
J

P
O


$
%&





Figure 1 Menaquinone-4 supplemented diet enhances
testosterone production in rat testis. Male Wistar rats were fed
with a control (Cont) or a MK-4-supplemented (MK-4 sup) diet for 5
weeks. Testosterone concentrations in the plasma from the tail vein
(A) and testis (B) and luteinizing hormone levels in plasma from the
abdominal aorta (C) were measured by ELISA. Data are represented
as means ± SE (n = 7 or 8). Values are significantly different from
those of the control group at *p < 0.05. †Plasma testosterone levels
in the MK-4 sup group were significantly increased when compared
with the control group (p < 0.05).
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Figure 2 Menaquinone-4 enhances testosterone production in
I-10 cells in the presence of cAMP. Mouse testis tumor-derived I-
10 cells were treated with dibutyryl-cAMP (db-cAMP, 3 μM) and
various concentrations of menaquinone-4 (MK-4) for 24 h. (A)
Testosterone levels in cultured medium were determined by ELISA.
Data are represented as means ± SE (n = 3). (B) The cell
proliferation assay was performed using the WST-1 assay kit. Data
are represented as means of relative absorbance values at 450 nm
± SE (n = 3). Values with different letters are significantly different at
p < 0.05.
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Page 4 of 9Therefore, enhanced testosterone secretion stimulated by
MK-4 treatment was not due to an increase of the number
of cells present.
In addition, MK-4 stimulated testosterone secretion
into the culture medium in a dose- and time-dependent
manner in the absence of db-cAMP (Figures 3A and
3B), although intracellular levels of testosterone were
not changed (data not shown). Previous studies have
shown that rat testis-derived R2C tumor cells synthesize
and secrete testosterone in a cAMP-independent man-
ner [20]; similarly, we observed that MK-4 stimulates
testosterone production in R2C cells without addition of
db-cAMP (Figure 3C). Together, these results indicate
that MK-4 directly enhances testosterone production in
Leydig-like tumor cells independently of intracellular
cAMP levels.
Warfarin does not inhibit enhanced testosterone
production by menaquinone-4
Next, we examined whether the formation of Gla pro-
teins is involved in enhanced testosterone production by
MK-4. The microsomal enzyme g-glutamylcarboxylase is
responsible for Gla formation and requires the reduced
hydroquinone form of vitamin K as a cofactor. Warfarin
is an antagonist of vitamin K epoxide reductase, which
generates the reduced form from the oxidized or epox-
ide forms of vitamin K. Thus, warfarin interferes indir-
ectly with Gla formation [21]. When I-10 cells were
treated with warfarin in the absence of MK-4, the tes-
tosterone levels in the culture medium were modestly
increased but not significantly different from control
cells (Figure 4). In the presence of MK-4, warfarin did
not inhibit the MK-4-stimulated testosterone produc-
tion, indicating that the stimulation of testosterone pro-
duction in I-10 cells by MK-4 is not mediated by the
formation of Gla proteins.
Menaquinone-4, but not vitamin K1, enhances
testosterone production in I-10 cells
We also examined whether vitamin K analogues other
than MK-4 stimulate testosterone production and found
that vitamin K1 does not enhance testosterone produc-
tion in I-10 cells (Figure 5A). Because vitamin K1 may
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Figure 3 Menaquinone-4 enhances testosterone production in
I-10 and R2C cells without cAMP stimulation. I-10 cells were
treated with various concentrations of menaquinone-4 (MK-4) for 24
h (A) or 30 μM MK-4 for different time periods (B). Rat testis tumor-
derived R2C cells were treated with various concentrations of MK-4
for 24 h (C). Testosterone levels in the culture medium were
determined by ELISA. Data are represented as means ± SE (n = 3).
Values indicated with different letters in A and C are significantly
different at p < 0.05. Values indicated by an asterisk in B are
significantly different at p < 0.05.
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Figure 4 Warfarin does not inhibit enhanced testosterone
production by menaquinone-4 in I-10 cells. I-10 cells were
treated with warfarin and menaquinone-4 (MK-4) simultaneously for
24 h, and testosterone levels in the culture medium were then
determined by ELISA. Data are represented as means ± SE (n = 3).
Values indicated with different letters are significantly different at p
< 0.05.
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Page 5 of 9not be incorporated into the cells, we determined the
cellular concentration of vitamin K by fluorescence-
HPLC after treating the cells with vitamin K1 for 3 h;
vitamin K1 was incorporated into the cells at one-fifth
the concentration of MK-4 present (Figure 5B). These
results demonstrate that MK-4 is well-incorporated into
I-10 cells and may stimulate testosterone production in
steroidogenic tumor cells, whereas vitamin K1 is incor-
porated in I-10 cells less than MK-4 and likely has no
stimulatory effect on testosterone production in these
cells.
Menaquinone-4 enhances testosterone production
through the activation of protein kinase A
CYP11A is the rate-limiting enzyme for testosterone
synthesis in Leydig cells. We determined the expression
levels of CYP11A and StAR proteins in I-10 cells treated
with MK-4. CYP11A levels were significantly higher in
cells at 1 h and 3 h post-MK-4 treatment compared to
levels in control cells (Figure 6A), and tended to be
higher at 9 h post-treatment; no difference of CYP11A
levels was found at 24 h post-treatment (data not
shown). The StAR expression levels in the cells were
unchanged after MK-4 treatment (Figure 6A). Further-
more, CYP11A expression levels in the testis from rats
fed a MK-4-supplemented diet for 5 weeks tended to be
higher than those of the control rats (Figure 6B). These
results indicate that MK-4 may enhance testosterone
production via upregulation of CYP11A.
It is well known that expression and activity of
CYP11A is regulated by protein kinase A (PKA). Vita-
min K stimulates the activities of PKA in various cul-
tured cell types although the detailed mechanism of this
activity has not been elucidated [22-24]. Thus, we exam-
ined whether MK-4 enhances testosterone production
via activation of PKA. Phosphorylation levels of the cat-
alytic subunit of PKA (p-PKA) in I-10 cells were signifi-
cantly increased by MK-4 treatment at the 2 h and 3 h
time points (Figures 7A and 7B), while total PKA levels
were not changed (data not shown). In addition, phos-
phorylation levels of CREB (p-CREB), a typical substrate
of PKA, were significantly increased by treatment with
MK-4 after 3 h (Figure 7B). Both p-PKA and p-CREB
levels were higher in I-10 cells at 9 h post-treatment
(data not shown). Conversely, enhanced testosterone
production induced by MK-4 was abolished by treat-
ment with H89, a specific inhibitor of PKA (Figure 8).
Together, these results indicate that MK-4 increases tes-
tosterone production in I-10 cells by upregulating
CYP11A expression through the activation of PKA.
Discussion
Vitamin K plays important roles in the blood coagula-
tion system and in bone formation. However, the tissue
distribution of vitamin K is not restricted to only the
liver and bone, and is also found in the brain, pancreas,
and gonads [11,25]. Specifically, analyses of vitamin K
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Figure 5 Menaquinone-4, but not vitamin K1, enhances
testosterone production in I-10 cells. I-10 cells were treated with
10 μM vitamin K1 (K1), or menaquinone-4 (MK-4) for 24 h, and
testosterone levels in the culture medium were determined by
ELISA (A), or I-10 cells were treated with K1 or MK-4 for 3 h, and
vitamin K levels in cells were determined by fluorescent-HPLC (B).
Data are represented as means ± SE (n = 3). Values with different
letters are significantly different at p < 0.05. ND, not detected.
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Figure 6 Menaquinone-4 increases CYP11A protein levels in I-
10 cells. I-10 cells were treated with menaquinone-4 (MK-4) for the
indicated time. After the treatment, whole cell extract was prepared,
and CYP11A and StAR levels were measured by Western blot
analysis (A). Whole cell extracts from the testis of rats fed control
(Cont) or MK-4 supplemented (MK-4 sup) diets for 5 weeks were
prepared, and CYP11A levels were measured by Western blot
analysis (B). Data are represented as mean ± SE (n = 3) normalized
to a-tubulin (A) or b-actin levels (B) and expressed as a fold-
increase/decrease of values compared to the MK-4 control cells or
the control diet group. Values with different letters are significantly
different at p < 0.05.
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4 is the most common form of vitamin K in these tis-
sues. MK-4 is obtained from the diet as well as from the
biological conversion of other vitamin K analogues
[3-8]. Novel functions of MK-4 have recently been
reported [16-18,23,24,26-30], but the physiological sig-
nificance of vitamin K conversion to MK-4 has not been
well characterized. To determine the function(s) of MK-
4 in the testis, we previously analyzed the changes of
gene expression in the testis of rats fed a vitamin K-defi-
cient diet in order to reduce the levels of MK-4 in the
testis [11]. We identified a positive correlation between
mRNA expression levels of CYP11A and concentrations
o fM K - 4i nt h et e s t i sa n df o u n dt h a tp l a s m aa n dt e s t i s
testosterone levels were significantly reduced under vita-
min K-deficient conditions without altering the levels of
plasma LH secreted from the pituitary gland. These
results suggested that MK-4 m a yb ei n v o l v e di ns t e r o i -
dogenesis in the testis. In our current study, we further
examined the effect of vitamin K on testosterone pro-
duction in the rat testis and testis-derived tumor cells.
Rats fed a diet supplemented with MK-4 displayed
higher plasma and testis testosterone levels when com-
pared to those of control rats. In addition, MK-4 treat-
ment of I-10 cells enhanced testosterone production
accompanied by the activation of PKA and elevation of
CYP11A protein levels, indicating a novel function of
vitamin K that has not been previously reported.
We found that vitamin K1 does not enhance testoster-
one production, while MK-4 significantly stimulates tes-
tosterone production and may play an important role in
steroidogenesis. Activation of PKA is crucial for steroid
production in Leydig cells [10]; therefore, vitamin K1
itself likely does not activate PKA in testis-derived cells.
Ichikawa et al. showed that MK-4, but not vitamin K1,
enhances mRNA levels of STC2 and GDF15, proteins
whose expression is regulated by PKA in human- and
mouse-derived osteoblasts [24]. However, Tsang and
Kamei showed that both vitamin K1 and MK-4 promote
nerve growth factor-dependent outgrowth of neuronal
cells, which is abolished in the presence of a PKA inhi-
bitor [22]. Discrepancies in results among experiments
may be due to differences of the uptake, stability, meta-
bolism, and solubility of each vitamin K cognate used to
treat the cells in the culture medium. Suhara et al.s t u -
died vitamin K uptake in cells by using stable isotope-
labeled vitamin K1 and MK-4 and found that MK-4 was
taken up more rapidly and was better incorporated into
HepG2 and MG-63 cells than vitamin K1 [31]. Our
results indicate that the apparent incorporation of MK-4
was significantly higher than the incorporation of vita-
min K1 after a 3 h treatment of I-10 cells (Figure 5B).
Thus, uptake and stability of each vitamin K analogue
may vary among different cell types. Because MK-4 is
converted from other vitamin K analogues in organs
and cultured cells, administered vitamin K1 may be con-
verted to MK-4, which in turn may stimulate PKA
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enhancement of testosterone production by menaquinone-4 in
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testosterone levels in the culture medium were determined by
ELISA. Data are represented as means ± SE (n = 3). Values with
different letters are significantly different at p < 0.05.
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Figure 7 Menaquinone-4 stimulates the protein kinase A
pathway in I-10 cells. I-10 cells were treated with menaquinone-4
(MK-4) or forskolin (Fsk) for 2 h. After the treatment, whole cell
extracts were prepared, and the phosphorylation levels of protein
kinase A (p-PKA) and CREB (p-CREB) were measured by Western blot
analysis (A). I-10 cells were treated with MK-4 for the indicated time.
After the treatment, p-PKA and p-CREB levels in the whole cell
extract were measured by Western blot analysis (B). Data are
represented as mean ± SE (n = 3), normalized to a-tubulin levels
and expressed as a fold-increase/decrease compared to the control
cell values (A: cells not treated with MK-4 or Fsk, B: cells treated
with MK-4 for 0 min). Values with different letters are significantly
different at p < 0.05.
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Page 7 of 9activity. However, we did not detect any MK-4 in vita-
min K1-treated I-10 cells at 3 h and 24 h post-treatment
(data not shown); therefore, vitamin K1 may be unable
to stimulate testosterone production in I-10 cells. Gera-
nylgeraniol, a side chain structure of MK-4, and its deri-
vative chemicals also enhanced testosterone production
in I-10 cells (unpublished data). Unsaturated isoprenyl
s i d ec h a i ni nM K - 4 ,b u tn o ti nv i t a m i nK 1,m a yb e
important to enhance testosterone production.
The holoenzyme of PKA is an inactivated hetero-tetra-
mer consisting of two regulatory subunits and two cata-
lytic subunits. After the elevation of intracellular cAMP
levels by various extracellular stimuli, cAMP binds to
the regulatory subunit and induces dissociation of the
catalytic subunits from the tetramer complex. Free cata-
lytic subunits of PKA then phosphorylate themselves
and substrates of PKA. MK-4 promotes PKA activation
[22-24] via a mechanism that has yet to be fully under-
stood. Vitamin D3 modulates intracellular cAMP levels
in thyroid cultured cells via activation of nuclear recep-
tor VDR [32], and MK-4 acts as a ligand for nuclear
receptor PXR (SXR) [26-29], suggesting that MK-4 regu-
lates gene expression, which leads to PKA activation.
However, we did not detect any PXR expression in the
I-10 cells. Synthetic vitamin K analogues such as vitamin
K3 (menadione) and vitamin K5 stimulate catechola-
mine-dependent cAMP levels in primary adipocytes
[33]. Both forms of synthetic vitamin K could contribute
to the stabilization of cAMP in cells, and so MK-4 may
also upregulate intracellular cAMP levels in the testis
and I-10 cells, although Otsuka et al. showed that MK-4
activates PKA without increasing intracellular levels of
cAMP [23]. Similar cAMP-independent activation of
PKA has been reported [34-37]. The catalytic subunit of
PKA interacts with the NFB-IBc o m p l e x ,a n di t s
kinase activity is inhibited by IB. Extracellular stimuli
for the activation of NFB (such as lipopolysaccharides
and inflammatory cytokines) and vasoactive peptide
endothelin-1 induce phosphorylation and degradation of
IB, and the kinase activity of PKA subsequently
emerges [35,36]. MK-4 suppresses the activation of IKK,
which phosphorylates IB for its degradation in the
NFB activation pathway [18,30]. Thus, MK-4 may lead
to the dissociation of inhibitory peptides (regulatory
subunits of PKA or IB) from the catalytic subunits of
PKA. In our preliminary studies, we found that MK-4
cannot activate purified PKA directly in vitro; therefore
further study is needed to determine the mechanism of
MK-4-mediated stimulation of PKA activity.
Conclusions
We found that MK-4 stimulates testosterone production
in rats and testis-derived tumor cells. Decreased testos-
terone in blood is frequently observed in elderly males
and is considered one of the pathogenic factors of age-
related diseases such as cancer, osteoporosis, athero-
sclerosis, and mental disease. MK-4 is already prescribed
as a therapeutic and preventive medicine for osteoporo-
sis in Japan and a few Asian countries. In addition, diets
containing large amounts of MK-4 and vitamin K1,a
precursor to MK-4, may contribute to the reduced risk
of age-related diseases by promoting increased testoster-
one production in the testis.
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